The enhanced ability of GoF ADAMTS‐13 to reduce the size of established pseudothrombi in vitro led us to examine whether or not it would remain effective at restoring blood flow in the AIS model when administration was delayed by 1 h. This evidence concerns the gene ADAMTS13 and androgen insensitivity syndrome.